The Atlantic Health Cancer Consortium Community Oncology Research Program (AHCC CORP)
The Atlantic Health Cancer Consortium Community Oncology Research Program (AHCC CORP)
批准号:
10228675
负责人:
Eric Whitman
金额:
$87.56万
依托单位国家:
美国
项目类别:
财政年份:
2019
资助国家:
美国
项目状态:
未结题
起止时间:
2019-08-27 至 2025-07-31
关键词:
AdultAgeAreaCancer ControlCancer Control ResearchCatchment AreaChildhoodClinical ResearchClinical TrialsCollaborationsCollectionCommunitiesCommunity Clinical Oncology ProgramCountyData CollectionDevelopmentEnrollmentGenomicsGeographyGoalsHealthHealth Services AccessibilityHealthcare SystemsIncidenceInfrastructureLanguageLeadershipMalignant Childhood NeoplasmMalignant NeoplasmsModalityNational Clinical Trials NetworkNatural Language ProcessingNew JerseyOncologistOncologyOutcomeParticipantPatient-Focused OutcomesPatientsPediatric HospitalsPhysiciansPopulationPopulation HeterogeneityProceduresProcessProtocols documentationProviderQuality of CareResearchResearch PersonnelScienceScientific Advances and AccomplishmentsSiteSpecimenTimeUnderrepresented Populationsbasecancer carecancer health disparitycancer preventioncare deliverychatbotclinical implementationclinically significantcommunity engagementcommunity settingdata submissiondemographicsdisparity reductionexperienceimaging studyimprovedinnovationinter-institutionalmedical specialistmedical specialtiesmembermentoring communitymolecular targeted therapiesorganizational structurepatient populationprecision medicineprevention clinical trialprogramsrecruitresearch studyretention ratescreeningsocial mediatumor
中文摘要
项目摘要
大西洋健康癌症联盟社区肿瘤学研究计划(AHCC-Corp)是第一个
新泽西州内的NCORP社区站点,结合了世界级的集体优势
提供社区肿瘤护理服务的医疗保健系统。AHC-Corp涵盖了地理上和
人口结构多样化的地区,占新泽西州人口的73%。AHC-Corp扩大了
NCORP网络由650万人组成;癌症发病率高于美国整体水平(477.5比441.2
每100,000个病例)。AHC-Corp的区域甚至进一步上升。
具体目标包括:1)增加成人和儿童对非传染性疾病癌症预防、控制、
筛查和护理提供研究,以及由
国家临床试验网络(NCTN)和生物样品收集。这将通过以下方式完成
在新泽西州创建了一个独特且史无前例的癌症护理联盟。该财团经历的
癌症研究人员在多个地点对成人和儿童癌症进行调查,其中包括三家儿童医院。
另外,联盟站点每年平均有130NCORP研究基地的参与者,但
在ACC-Corp的领导和基础设施支持下,附属公司现在准备进一步
增加应计项目。2)加强社区对癌症控制和预防临床试验的参与
以及由NCORP在美国癌症协会-集水区进行的癌症护理提供研究。
将通过创新方法提高参与度,使医生、患者和
社区。的发展主要包括社交媒体传播和互动的视频片段
Chatbot功能由自然语言处理提供支持,允许在
支持多种语言的癌症差异整合。此外,ahc-corp有一个明确定义的
确定NCORP和NCTN试验激活优先级的流程,以及支持成功研究的程序
跨站点的应计和数据收集。AHCCCorp还将支持和指导社区肿瘤学家
新泽西州中部和北部的其他医疗专家,进一步提高癌症护理服务的能力
研究。3)有助于开发和实施具有临床意义的研究
将不同人群的独特研究需求纳入AHC NCORP流域
领域,利用现有肿瘤学专科医生和其他供应商的专业知识
我们的附属网络。拥有成熟的临床和研究专业知识,涵盖多种肿瘤类型和
将利用AHCC-Corp医生和其他提供者的研究模式来支持NCORP
通过积极参与研究基地和其他NCORP范围的活动来实现总体规划目标
研究领导委员会。
英文摘要
Project Summary
Atlantic Health Cancer Consortium Community Oncology Research Program (AHCC-CORP) is the first
NCORP Community Site within the state of New Jersey and combines the collective strengths of world-class
healthcare systems with community oncology care delivery. AHCC-CORP covers a geographically and
demographically diverse area representing 73% of New Jersey’s population. AHCC-CORP expands the
NCORP network by 6.5M people; with a higher cancer incidence rate than the US as a whole (477.5 vs 441.2
cases per 100,000). Regions of AHCC-CORP are even further elevated.
Specific Aims include: 1) Increase adult and pediatric accruals to NCI cancer prevention, control,
screening, and care delivery research studies, as well as treatment and imaging studies conducted by
the National Clinical Trials Network (NCTN) and biospecimen collection. This will be accomplished by
creating a unique and unprecedented cancer care consortium in New Jersey. The Consortium has experienced
cancer investigators in adult and pediatric cancers across multiple sites, including three children's hospitals.
Separately, Consortium sites annually accrue an average of 130 participants to NCORP Research Bases, but
with the leadership and infrastructure support of AHCC-CORP, affiliates are now poised to even further
increase accruals. 2) Enhance community engagement in cancer control and prevention clinical trials
and Cancer Care Delivery Research (CCDR) conducted by NCORP in the AHCC-CORP catchment area.
Engagement will be enhanced through innovative approaches that effectively engage physicians, patients, and
the community. Developments notably include video vignettes for social media dissemination and interactive
chatbot capabilities powered by natural language processing, allowing recruitment/retention strategies in
multiple languages in support of cancer disparities integration. Additionally, AHCC-CORP has a clearly-defined
process for prioritizing NCORP and NCTN trials for activation, and procedures in support of successful study
accrual and data collection across sites. AHCC-CORP will also support and mentor community oncologists and
other medical specialists in central and northern New Jersey, furthering capabilities in cancer care delivery
research. 3) Contribute to the development and implementation of clinically significant studies that
incorporate the unique research needs of the diverse population within the AHCC NCORP catchment
area, leveraging the expertise of established oncology specialty physicians and other providers within
our affiliate network. The established clinical and research expertise, across multiple tumor types and
research modalities, of AHCC-CORP physicians and other providers will be leveraged to support NCORP
overarching programmatic goals through active involvement in Research Bases and other NCORP-wide
research leadership committees.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
The Atlantic Health Cancer Consortium Community Oncology Research Program (AHCC CORP)
-
批准号:10668415
-
项目类别:
-
资助金额:$92.49万
-
财政年份:2019
-
负责人:Eric Whitman
-
依托单位:
The Atlantic Health Cancer Consortium Community Oncology Research Program (AHCC CORP)
-
批准号:10453746
-
项目类别:
-
资助金额:$87.07万
-
财政年份:2019
-
负责人:Eric Whitman
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位:
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
-
批准号:81973577
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:辛贵忠
-
依托单位:
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
-
批准号:81602908
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:刘括
-
依托单位: